Skip to content

Transcranial alternating current stimulation intervention for children with autism spectrum disorder

Non-invasive targeted CFC neuroregulation technology for children with autism spectrum disorder

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120068
Enrollment
Unknown
Registered
2026-03-09
Start date
2025-10-29
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Experimental group:Transcranial alternating current stimulation, Neurofeedback training
Control group:sham Transcranial Alternating Current Stimulation, sham Neurofeedback training

Sponsors

Ningbo Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 3 - 12 years old, gender not restricted; 2. The guardian of the child must provide informed consent and sign the consent form; 3. All children with ASD are diagnosed as having autism by experienced doctors based on the DSM-V standards.

Exclusion criteria

Exclusion criteria: 1. The patient has other brain development disorders such as ADHD, RETT syndrome and developmental delay; 2. The patient has severe physical diseases, a history of brain trauma, and a history of epilepsy; 3. Received non-invasive stimulation such as tDCS and TMS within 6 weeks; 4. In addition to conventional behavioral training, has taken psychotropic drugs for mental disorders; 5. Has not signed the informed consent form.

Design outcomes

Primary

MeasureTime frame
Functional Connectivity;Alpha Power;sample entropy;Electroencephalogram microstates;

Secondary

MeasureTime frame
Behavioral scale score;

Countries

China

Contacts

Public ContactNan Liu

Ningbo Rehabilitation Hospital

953092491@qq.com+86 159 9057 0185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026